Growth on stimulant medication; clarifying the confusion: a review
Open accessAbstract
AIMS: To get an overview of the studies of growth in height in children with attention deficit hyperactivity disorder (ADHD) treated with stimulant medication, to establish the consistencies and to try to resolve the discrepancies. METHODS: Twenty nine studies were reviewed following a Medline search: 22 related to children, six to late adolescents or adults, and one to children and adults. RESULTS: Children: Eleven studies gave results consistent with height attenuation on stimulant medication: eight were longitudinal, one was cross-sectional, and two showed growth rebound on ceasing medication. Studies with negative findings were inadequately powered (n = 3), lacked controls or statistical analysis (n = 3), measured height velocity without reference to treatment duration (n = 2), or used inappropriate growth parameters (n = 1), controls (n = 1), or normative data (n = 1). Late adolescents/adults treated with stimulant medication in childhood: Two studies associated childhood gastrointestinal side effects with attenuated late adolescent or adult height; all six cross-sectional studies had negative findings. The methodologies varied widely but there was some consistency in the degree of attenuation shown in studies with positive findings. The most sensitive methods analysed the changes in z-scores (standard deviation scores) or calculated the height deficits from paired measurements taken before and after an initial period of treatment with stimulant medication. The height deficit amounted to approximately 1 cm/year during the first 1-3 years of treatment. CONCLUSIONS: Further research is needed into the causal mechanisms, the rate of physical maturation, and the long term implications for final stature.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Studies providing longitudinal data suggest that treating children with ADHD with stimulant medication generally results in a reduction in both height and weight gain.
“Studies providing longitudinal data suggest that treating children with ADHD with stimulant medication generally results in a reduction in both height and weight gain [37, 112].”
From European guidelines on managing adverse effects of medication for ADHD (2011) · cites this paper as [112]
Periods of treatment cessation (drug holidays) seem to result in rebound growth for children who experienced deficits during treatment, with children seeming to return to their normal growth percentiles and trajectory.
“Periods of treatment cessation (drug holidays) seem to result in rebound growth for children who experienced deficits during treatment, with children seeming to return to their normal growth percentiles and trajectory [37, 112].”
From European guidelines on managing adverse effects of medication for ADHD (2011) · cites this paper as [112]
These results are consistent with previously reported evidence that psychostimulants are associated with loss of appetite and weight loss.
“These results are consistent with previously reported evidence that psychostimulants are associated with loss of appetite and weight loss.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
(1976) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1976.tb115280.x · Cited by 5,225 · see citing works
Curriculum, K. (2006) · Cited by 588 · see citing works
MTA Cooperative Group (2004) · PEDIATRICS · doi:10.1542/peds.113.4.762 · Cited by 384 · see citing works
Depression of Growth in Hyperactive Children on Stimulant Drugs
Safer, D. J., Allen, R. P., & Barr, E. (1972) · New England Journal of Medicine · doi:10.1056/nejm197208032870503 · Cited by 251 · see citing works
Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?
SPENCER, T. J., BIEDERMAN, J., HARDING, M., O'DONNELL, D., FARAONE, S. V., & WILENS, T. E. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199611000-00014 · Cited by 238 · see citing works
Gadow, K. D., Sverd, J., Sprafkin, J. N., Nolan, E. E., & Grossman, S. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.4.330 · Cited by 234 · see citing works
Hyperactive boys almost grown up. III. Methylphenidate effects on ultimate height.
Klein, R., & Mannuzza, S. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800360079012 · Cited by 220 · see citing works
Young Adult Outcome of Hyperactive Children Who Received Long-term Stimulant Treatment
HECHTMAN, L., WEISS, G., & PERLMAN, T. (1984) · Journal of the American Academy of Child Psychiatry · doi:10.1016/s0002-7138(09)60501-x · Cited by 178 · see citing works
VITIELLO, B., SEVERE, J. B., GREENHILL, L. L., ARNOLD, L. E., ABIKOFF, H. B., BUKSTEIN, O. G., ELLIOTT, G. R., HECHTMAN, L., JENSEN, P. S., HINSHAW, S. P., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00013 · Cited by 163 · see citing works
Safer, D. J., & Allen, R. P. (1973) · PEDIATRICS · doi:10.1542/peds.51.4.660 · Cited by 158 · see citing works
Methylphenidate and Growth in Hyperactive Children: A Controlled Withdrawal Study
Klein, R. G. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800360075011 · Cited by 156 · see citing works
WILENS, T., PELHAM, W., STEIN, M., CONNERS, C. K., ABIKOFF, H., ATKINS, M., AUGUST, G., GREENHILL, L., MCBURNETT, K., PALUMBO, D., et al. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000046814.95464.7d · Cited by 148 · see citing works
Forfar, J. O., & Arneil, G. C. (1986) · Medical Entomology and Zoology · Cited by 145 · see citing works
One-year follow-up of hyperactive boys treated with imipramine or methylphenidate
Quinn, P. O., & Rapoport, J. L. (1975) · American Journal of Psychiatry · doi:10.1176/ajp.132.3.241 · Cited by 141 · see citing works
Growth of Hyperactive Children on Maintenance Regimen of Methylphenidate
Mattes, J. A. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790030087011 · Cited by 139 · see citing works
Biederman, J., Faraone, S. V., Monuteaux, M. C., Plunkett, E. A., Gifford, J., & Spencer, T. (2003) · Pediatrics · doi:10.1542/peds.111.5.1010 · Cited by 133 · see citing works
Slowing of growth in height and weight on stimulants: A characteristic pattern
Poulton, A., & Cowell, C. (2003) · Journal of Paediatrics and Child Health · doi:10.1046/j.1440-1754.2003.00107.x · Cited by 132 · see citing works
Self-citationGrowth rebound after termination of stimulant drugs
Safer, D. J., Allen, R. P., & Barr, E. (1975) · The Journal of Pediatrics · doi:10.1016/s0022-3476(75)80720-7 · Cited by 123 · see citing works
Growth of Hyperactive Children Treated With Methylphenidate
Satterfield, J. H. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780020102011 · Cited by 114 · see citing works
Growth Deficits in Children With Attention Deficit Hyperactivity Disorder
Spencer, T. J., Biederman, J., & Wilens, T. E. (1998) · PEDIATRICS · doi:10.1542/peds.102.s3.501 · Cited by 107 · see citing works
KRAMER, J. R., LONEY, J., PONTO, L. B., ANN ROBERTS, M., & GROSSMAN, S. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200004000-00022 · Cited by 99 · see citing works
Childhood Chemotherapy and Later Drug Abuse and Growth Curve: A Follow-Up Study of 30 Adolescents
BECK, L., LANGFORD, W. S., MACKAY, M., & SUM, G. (1975) · American Journal of Psychiatry · doi:10.1176/ajp.132.4.436 · Cited by 93 · see citing works
Daily Methylphenidate Use Slows the Growth of Children: A Community Based Study
Lisska, M. C., & Rivkees, S. A. (2003) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2003.16.5.711 · Cited by 75 · see citing works
Growth of Hyperkinetic Children Taking Methylphenidate, Dextroamphetamine, or Imipramine/Desipramine
Gross, M. D. (1976) · PEDIATRICS · doi:10.1542/peds.58.3.423 · Cited by 73 · see citing works
Does extended medication with amphetamine or methylphenidate reduce growth in hyperactive children?
Sund, A. M., & Zeiner, P. (2002) · Nordic Journal of Psychiatry · doi:10.1080/08039480252803936 · Cited by 46 · see citing works
Effects of methylphenidate on early adolescent growth
Vincent, J., Varley, C., & Leger, P. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.4.501 · Cited by 45 · see citing works
Growth Hormone, Prolactin, and Growth Responses in Hyperkinetic Males Treated with D-Amphetamine
Greenhill, L. L., Puig-Antich, J., Chambers, W. J., Rubinstein, B., Halpern, F. S., & Sachar, E. J. (1981) · Journal of the American Academy of Child Psychiatry · doi:10.1016/s0002-7138(09)60719-6 · Cited by 39 · see citing works
Effect of Methylphenidate Hydrochloride on Stature of Hyperactive Children
Kalachnik, J. E., Sprague, R. L., Sleator, E. K., Cohen, M. N., & Ullmann, R. K. (1982) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1982.tb13669.x · Cited by 39 · see citing works
Growth Deficits in Children Treated with Desipramine: A Controlled Study
Spencer, T. J., Biederman, J., WRIGHT, V., & Danon, M. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199203000-00009 · Cited by 37 · see citing works
Loney, J., Whaley-Klahn, M. A., Ponto, L. L. B., & Adney, K. (1981) · PubMed · Cited by 32 · see citing works
McNutt, B., Je, B., & Boileau, R. A. (1976) · PubMed · Cited by 25 · see citing works
Ba, M., Ra, B., & Mn, C. (1977) · PubMed · Cited by 23 · see citing works
Growth of Hyperactive Children
Millichap, J. G., & MillichapM (1975) · New England Journal of Medicine · doi:10.1056/nejm197506122922424 · Cited by 16 · see citing works
Growth of Hyperactive Children Treated with Methylphenidate
Millichap, J. G. (1978) · Journal of Learning Disabilities · doi:10.1177/002221947801100906 · Cited by 14 · see citing works
Currie, W. B. (2017) · CRC Press eBooks · doi:10.1201/9780203738047-8 · Cited by 13 · see citing works
MBD children--variability in developmental patterns or growth inhibitory effect of stimulants?
Kaffman, M., Sher, A., & Bar-Sinai, N. (1979) · PubMed · Cited by 12 · see citing works
The status of clinical psychopharmacology in residency training programs [proceedings].
Wienckowski, L. A. (1977) · PubMed · Cited by 10 · see citing works
The Individualized Education Program - Part 1: Procedural Guidelines
Turnbull, A. P., Strickland, B. B., & Hammer, S. E. (1978) · Journal of Learning Disabilities · doi:10.1177/002221947801100106 · Cited by 8 · see citing works
M., M. M. (2003) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200310000-00016 · Cited by 7 · see citing works
Barchas, J. D., & Elliot, G. R. F. (1976) · PubMed · Cited by 6 · see citing works
Childhood chemotherapy and later drug abuse and growth curve: a follow- up study of 30 adolescents
(1975) · American Journal of Psychiatry · doi:10.1176/ajp.132.4.436a · Cited by 1 · see citing works
Gaisford, W. (1966) · BMJ · doi:10.1136/bmj.2.5521.1067-c · Cited by 1 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Pliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765 · see citing works
Sharma, A., & Couture, J. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028013510699 · Cited by 516 · see citing works
Endocrine and Metabolic Adverse Effects of Psychotropic Medications in Children and Adolescents
Correll, C. U., & Carlson, H. E. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000220851.94392.30 · Cited by 403 · see citing works
European guidelines on managing adverse effects of medication for ADHD
(for the European Guidelines Group), Graham, J., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Döpfner, M., Hamilton, R., Hollis, C., et al. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-010-0140-6 · Cited by 374 · see citing works
Pharmacologic Treatment of Attention Deficit–Hyperactivity Disorder
Cortese, S. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1917069 · Cited by 342 · see citing works
Cortese, S., Holtmann, M., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Graham, J., Taylor, E., Sergeant, J., et al. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12036 · Cited by 336 · see citing works
Potential Adverse Effects of Amphetamine Treatment on Brain and Behavior: A Review
Arcos-Burgos, M., Jain, M., Acosta, M. T., Shively, S., Stanescu, H., Wallis, D., Domené, S., Velez, J. I., Karkera, J., Balog, J. Z., et al. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.90 · Cited by 423 · see citing works
Attention Deficit–Hyperactivity Disorder in Children and Adolescents
Feldman, H. M., & Reiff, M. I. (2014) · New England Journal of Medicine · doi:10.1056/nejmcp1307215 · Cited by 245 · see citing works
Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Kazda, L., Bell, K., Thomas, R., McGeechan, K., Sims, R., & Barratt, A. L. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.5335 · Cited by 224 · see citing works
Graham, J., & Coghill, D. (2008) · CNS Drugs · doi:10.2165/00023210-200822030-00003 · Cited by 185 · see citing works
Attention-Deficit Hyperactivity Disorder in Girls
Staller, J. A., & Faraone, S. V. (2006) · CNS Drugs · doi:10.2165/00023210-200620020-00003 · Cited by 178 · see citing works
Pliszka, S. R. (2007) · Neuropsychology Review · doi:10.1007/s11065-006-9017-3 · Cited by 158 · see citing works
Vitiello, B. (2008) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2007.11.010 · Cited by 110 · see citing works
Carucci, S., Balia, C., Gagliano, A., Lampis, A., Buitelaar, J. K., Danckaerts, M., Dittmann, R., Garas, P., Hollis, C. P., Inglis, S. K., et al. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.09.031 · Cited by 104 · see citing works
van de Loo-Neus, G. H. H., Rommelse, N., & Buitelaar, J. K. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.03.008 · Cited by 98 · see citing works
Dittmann, R. W., Cardo, E., Nagy, P., Anderson, C. S., Bloomfield, R., Caballero, B., Higgins, N., Hodgkins, P., Lyne, A., Civil, R., et al. (2013) · CNS Drugs · doi:10.1007/s40263-013-0104-8 · Cited by 88 · see citing works
Pelham, W. E., Burrows-MacLean, L. D., Gnagy, E. M., Fabiano, G. A., Coles, E. K., Wymbs, B. T., Chacko, A., Walker, K. S., Wymbs, F. A., Garefino, A. C., et al. (2014) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-013-9843-8 · Cited by 85 · see citing works
Neurodevelopmental Behavioral and Cognitive Disorders
Jeste, S. (2015) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000466661.89908.3c · Cited by 71 · see citing works
Drug Holidays From ADHD Medication
Ibrahim, K., & Donyai, P. (2014) · Journal of Attention Disorders · doi:10.1177/1087054714548035 · Cited by 68 · see citing works
Shier, A. C., Reichenbacher, T., Ghuman, H. S., & GHUMAN, J. K. (2012) · Journal of Central Nervous System Disease · doi:10.4137/jcnsd.s6691 · Cited by 69 · see citing works
Poulton, A. S., BRIODY, J. N., McCorquodale, T., Melzer, E., Herrmann, M., Baur, L. A., & Duque, G. (2012) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2012-30 · Cited by 62 · see citing works
Self-citationLong-Term Effects of Methylphenidate Transdermal Delivery System Treatment of ADHD on Growth
FARAONE, S. V., & GIEFER, E. E. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31806ad1d7 · Cited by 55 · see citing works
Şahin, S., Yuce, M., Alaçam, H., Karabekiroğlu, K., Say, G. N., & Şalış, O. (2014) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2014.940054 · Cited by 52 · see citing works
Current issues around the pharmacotherapy of ADHD in children and adults
Meijer, W. M., Faber, A., van den Ban, E. F., & Tobi, H. (2009) · Pharmacy World & Science · doi:10.1007/s11096-009-9302-3 · Cited by 52 · see citing works
Feuer, A. J., Thai, A., Demmer, R. T., & Vogiatzi, M. G. (2016) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2016.2804 · Cited by 52 · see citing works
Leptin Gene –2548G/A variants predict risperidone-associated weight gain in children and adolescents
Calarge, C. A., Ellingrod, V. L., Zimmerman, B. M., Ación, L., Sivitz, W. I., & Schlechte, J. (2009) · Psychiatric Genetics · doi:10.1097/ypg.0b013e3283328e06 · Cited by 49 · see citing works
Inglis, S. K., Carucci, S., Garas, P., Häge, A., Banaschewski, T., Buitelaar, J. K., Dittmann, R., Falissard, B., Hollis, C. P., Kovshoff, H., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010433 · Cited by 49 · see citing works
Katz, M., Adar Levine, A., Kol-Degani, H., & Kav-Venaki, L. (2010) · Journal of Attention Disorders · doi:10.1177/1087054709356388 · Cited by 48 · see citing works
Chronic exposure to methylphenidate impairs appendicular bone quality in young rats
Komatsu, D. E., Thanos, P. K., Mary, M. N., Janda, H. A., John, C. M., Robison, L. S., Ananth, M. R., Swanson, J. M., Volkow, N. D., & Hadjiargyrou, M. (2012) · Bone · doi:10.1016/j.bone.2012.03.011 · Cited by 47 · see citing works
Fitness Level and Gross Motor Performance of Children With Attention-Deficit Hyperactivity Disorder
Verret, C., Gardiner, P. F., & Béliveau, L. (2010) · Adapted Physical Activity Quarterly · doi:10.1123/apaq.27.4.337 · Cited by 48 · see citing works
Poulton, A. S., Bui, Q., Melzer, E., & Evans, R. (2015) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000109 · Cited by 44 · see citing works
Self-citationRacicka, E., Hanć, T., Kuć, K., Bryńska, A., & Wolańczyk, T. (2015) · Journal of Attention Disorders · doi:10.1177/1087054715578272 · Cited by 42 · see citing works
ADHD and growth: anthropometric changes in medicated and non-medicated ADHD boys.
Ptáček, R., Kuželová, H., Paclt, I., Žukov, I., & Fischer, S. (2009) · PubMed · Cited by 40 · see citing works
Najib, J. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.01.015 · Cited by 40 · see citing works
Neuropsychological Effects of Stimulant Medication on Children’s Learning and Behavior
Brown, R. T., & Borden, K. A. (1989) · Critical issues in neuropsychology · doi:10.1007/978-1-4899-6807-4_24 · Cited by 39 · see citing works
ADHD and overweight in boys: cross-sectional study with birth weight as a controlled factor
Hanć, T., Słopień, A., Wolańczyk, T., Dmitrzak‐Węglarz, M., Szwed, A., Czapla, Z., Durda, M., Ratajczak, J., & Cieślik, J. J. (2014) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-014-0531-1 · Cited by 38 · see citing works
Age-Grouped Differences in Adverse Drug Events from Psychotropic Medication
Safer, D. J. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.0152 · Cited by 38 · see citing works
Díez‐Suárez, A., Vallejo-Valdivielso, M., Marín-Méndez, J. J., de Castro‐Manglano, P., & Soutullo, C. A. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2016.0150 · Cited by 37 · see citing works
Powell, S. G., Frydenberg, M., & Thomsen, P. H. (2015) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-015-0082-3 · Cited by 36 · see citing works
Howard, J. T., Walick, K. S., & Rivera, J. C. (2015) · Journal of Pediatric Orthopaedics · doi:10.1097/bpo.0000000000000651 · Cited by 35 · see citing works
Waxmonsky, J. G., Pelham, W. E., Campa, A. L., Waschbusch, D. A., Li, T., Marshall, R., Babocsai, L., Humphery, H., Gnagy, E. M., Swanson, J. M., et al. (2019) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2019.08.472 · Cited by 35 · see citing works
Durá-Travé, T., Yoldi-Petri, M. E., Gallinas-Victoriano, F., & Zardoya-Santos, P. (2011) · Journal of Child Neurology · doi:10.1177/0883073811422752 · Cited by 34 · see citing works
Nanda, A., Janga, L. S. N., Sambe, H. G., Yasir, M. B., Man, R. K., Gogikar, A., & Mohammed, L. (2023) · Cureus · doi:10.7759/cureus.45995 · Cited by 33 · see citing works
Anthropometric changes in non-medicated ADHD boys.
Ptáček, R., Kuželová, H., Paclt, I., Žukov, I., & Fischer, S. (2009) · PubMed · Cited by 33 · see citing works
The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder
Ashton, H., Gallagher, P., & Moore, B. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106061710 · Cited by 31 · see citing works
Leddy, J. J., Waxmonsky, J. G., Salis, R. J., Paluch, R. A., Gnagy, E. M., Mahaney, P., Erbe, R. W., Pelham, W. E., & Epstein, L. H. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.046 · Cited by 27 · see citing works
Long-Term Effects of ADHD Medication on Adult Height
Peyre, H., Hoertel, N., Cortese, S., Acquaviva, É., Limosin, F., & Delorme, R. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13l08580 · Cited by 25 · see citing works
de Gregorio, M. V., Pérez, L. M. R., & Moro, M. I. B. (2019) · Retos · doi:10.47197/retos.v36i36.68502 · Cited by 24 · see citing works
Gender Bias in Children Receiving Growth Hormone Treatment
Hughes, I. P., Choong, C. S., Cotterill, A. M., Harris, M. A., & Davies, P. S. W. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1563 · Cited by 24 · see citing works
Methylphenidate HCL for the treatment of ADHD in children and adolescents
Childress, A. C. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1182986 · Cited by 23 · see citing works
Wei, W., Chen, L., Zhou, H., Liu, J., Zhang, Y., Feng, S., Bai, Y., Leng, Y.-E., Chang, E., & Huang, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1208456 · Cited by 27 · see citing works
Kim, H., Kim, S., Shon, S., Lee, J., Lee, H., & Choi, J. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0025 · Cited by 22 · see citing works
Jasper, B. W., Conklin, H. M., Lawford, J., Morris, E. B., Howard, S. C., Wu, S., Xiong, X., Shelso, J., & Khan, R. B. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21770 · Cited by 21 · see citing works
Changes and Challenges: Managing ADHD in a Fast-Paced World
Manos, M. J., Tom-Revzon, C., Bukstein, O. G., & Crismon, M. L. (2007) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2007.13.9-b.1 · Cited by 18 · see citing works
Baweja, R. K., Hale, D. E., & Waxmonsky, J. G. (2021) · CNS Drugs · doi:10.1007/s40263-021-00841-w · Cited by 19 · see citing works
assessment, I. A. M. H., (inattention, T. C. S. S. F. A. B. S. A. Q. R. T. M. S. D. O. A., impulsivity, the, A. H. A. A. W. S. S. C. I. T. S. Q. S. B. A. R. O. T. N. O. T. C. C. R. S. O. S. Q. C., symptoms of ADHD can also be included in clinic/office registration materials to be completed by parents before visits or in the waiting room before the evaluation. If a parent reports that the patient suffers from any symptoms of ADHD that induce impairment or if the patient scores in the clinical range for ADHD symptoms on a rating scale, & indicated., T. A. F. E. F. A. A. S. O. I. T. N. R. I. (2008) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.6.3.foc401 · Cited by 18 · see citing works
Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder
Poulton, A. S. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.4.551 · Cited by 18 · see citing works
Self-citationWaxmonsky, J. G., Pelham, W. E., Baweja, R. K., Hale, D. E., & Pelham, W. E. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.09.030 · Cited by 17 · see citing works
Stimulants and growth in children with attention-deficit/hyperactivity disorder
Negrao, B. L., & Viljoen, M. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.03.015 · Cited by 17 · see citing works
Hanć, T., Cieślik, J. J., Wolańczyk, T., & Gajdzik, M. (2012) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.0113 · Cited by 16 · see citing works
Janols, L., Liliemark, J. O., Klintberg, K., & von Knorring, A. (2009) · Nordic Journal of Psychiatry · doi:10.3109/08039480903154534 · Cited by 15 · see citing works
Poulton, A. S. (2006) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000236394.94827.4c · Cited by 15 · see citing works
Self-citationMistakes and misconduct in the research literature: retractions just the tip of the iceberg
Poulton, A. (2007) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2007.tb00917.x · Cited by 14 · see citing works
Self-citationStimulant Medication Use and Response to Growth Hormone Therapy: An NCGS Database Analysis
Frindik, J. P., Morales, A. E., Fowlkes, J. L., Kemp, S. F., Thrailkill, K. M., Lippe, B. M., & Dana, K. (2009) · Hormone Research in Paediatrics · doi:10.1159/000232491 · Cited by 14 · see citing works
Safety of psychotropic drug prescribed for attention-deficit/hyperactivity disorder in Italy
Panei, P., Arcieri, R., Bonati, M. R., Bugarini, M., Didoni, A., & Germinario, E. A. P. (2010) · Adverse Drug Reaction Bulletin · doi:10.1097/fad.0b013e3283383a63 · Cited by 13 · see citing works
Growth perturbations from stimulant medications and inhaled corticosteroids
Richardson, E., Seibert, T. S., & Uli, N. K. (2017) · Translational Pediatrics · doi:10.21037/tp.2017.09.14 · Cited by 12 · see citing works
Takon, I. (2011) · Annals of General Psychiatry · doi:10.1186/1744-859x-10-25 · Cited by 11 · see citing works
Cuttler, L., Misra, M., & Koontz, M. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00022-6 · Cited by 11 · see citing works
Selective Serotonin Reuptake Inhibitors Reduce Longitudinal Growth in Risperidone-Treated Boys
Calarge, C. A., Mills, J. A., Karaviti, L. P., Teixeira, A. L., Zemel, B. S., & Garcia, J. M. (2018) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2018.05.040 · Cited by 10 · see citing works
Koonrungsesomboon, K., & Koonrungsesomboon, N. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2019.0115 · Cited by 10 · see citing works
Cuttler, L., & Misra, M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00025-3 · Cited by 10 · see citing works
Rose, S. R., Reeves, G., Gut, R., & Germak, J. A. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.08.036 · Cited by 9 · see citing works
The Effects of Chronic Psychostimulant Administration on Bone Health: A Review
Nowak, J., Aronin, J., Beg, F., O'Malley, N. T., Ferrick, M. R., Quattrin, T., Pavlesen, S., Hadjiargyrou, M., Komatsu, D. E., & Thanos, P. K. (2024) · Biomedicines · doi:10.3390/biomedicines12081914 · Cited by 8 · see citing works
Nutrition Management of Children With Attention Deficit Hyperactivity Disorder
Phillips, W. (2014) · ICAN Infant Child & Adolescent Nutrition · doi:10.1177/1941406414551202 · Cited by 9 · see citing works
Espinosa, A. L. (2006) · Hispana · Cited by 7 · see citing works
Effect of Stimulants on Growth of ADHD Children: A Critical Review
Ptáček, R., Kuželová, H., & Paclt, I. (2009) · Activitas Nervosa Superior · doi:10.1007/bf03379556 · Cited by 7 · see citing works
The Impact of an Adapted Climbing Program on Children with Attention-Deficit/Hyperactivity Disorder
Angelini, E., Oriel, K. N., Myers, G. M., Cook, K. D. A., Drawbaugh, R. M., & Price, J. (2020) · International Journal of Physical Education Fitness and Sports · doi:10.34256/ijpefs2047 · Cited by 5 · see citing works
Velayutham, V., Chakrabarty, S., Greer, R. M., Cotterill, A. M., & Leong, G. M. (2024) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2024-0268 · Cited by 5 · see citing works
Dobie, C., Wb, D., Heim, C. C., Huxsahl, J. E., Karasov, R., Neumann, A. V., & Spinner, P. (2012) · Cited by 5 · see citing works
Çevikaslan, A., Parlak, M., Elli̇dağ, H. Y., Kulaksızoğlu, S., & Yılmaz, N. (2021) · Scandinavian Journal of Child and Adolescent Psychiatry and Psychology · doi:10.21307/sjcapp-2021-018 · Cited by 5 · see citing works
Graham, J. S., Seth, S., & Coghill, D. (2007) · Medicine · doi:10.1016/j.mpmed.2007.01.002 · Cited by 5 · see citing works
Schneider, G., Banaschewski, T., Feldman, B. L., Gustafsson, P. A., Murphy, B. P., Reynolds, M. W., Coghill, D., & Spalding, W. M. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2018.0132 · Cited by 5 · see citing works
Tenore, A., & Tenore, A. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.08.004 · Cited by 5 · see citing works
Stimulant Medications and Growth
Poulton, A. S., & Nanan, R. K. H. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31819e3f60 · Cited by 5 · see citing works
Self-citationPliszka, S. R. (2012) · Wiley eBooks · doi:10.1002/9781119958338.ch6 · Cited by 5 · see citing works
Chen, S., Wu, T. M. S., Li, H., Shou, J., Qin, J., Wu, G.-T., Cheng, W., & Yeung, W.-F. (2025) · Nutrients · doi:10.3390/nu17030513 · Cited by 4 · see citing works
Gender specific short stature in male adolescents with obsessive-compulsive disorder
Hu, Y.-P., Wehrly, R., Gorrindo, T., Hezel, D. M., Gironda, C. M., Jenike, M. A., & Stewart, S. E. (2012) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2012.07.009 · Cited by 3 · see citing works
Bodey, C. (2011) · Clinical Medicine Insights Therapeutics · doi:10.4137/cmt.s6615 · Cited by 4 · see citing works
Durá-Travé, T., Yoldi-Petri, M. E., & Zardoya-Santos, P. (2011) · Revista de Neurología · doi:10.33588/rn.5305.2011284 · Cited by 4 · see citing works
Neuropsychological Effects of Stimulant Medication on Children’s Learning and Behavior
Brown, R. T., & Daly, B. P. (2008) · Springer eBooks · doi:10.1007/978-0-387-78867-8_22 · Cited by 4 · see citing works
Dexmethylphenidate for attention deficit hyperactivity disorder
Coury, D. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903386284 · Cited by 2 · see citing works
Methylphenidate and growth in ADHD children
Ptáček, R., & Kuželová, H. (2011) · Cited by 3 · see citing works
Jackson, G. E. (2009) · doi:10.1007/978-1-137-02058-1_10 · Cited by 3 · see citing works
Oxley, C. J., Moghraby, O. S., Samuel, R., & Joyce, D. W. (2018) · BMJ Open Quality · doi:10.1136/bmjoq-2017-000213 · Cited by 3 · see citing works
Stolzer, J. M. (2012) · Ethical Human Psychology and Psychiatry · doi:10.1891/1559-4343.14.1.5 · Cited by 2 · see citing works
Clinical Practice Guideline for Patients with Attention Deficit/Hyperactivity Disorder
Carlton, T. G., Donachie, N., Frampton, K. K., Henschen, G., Kumar, P. E., Parrot, L. A., Smith, C. A., Tamil, F. A., Valenti, A. M., & Waxenberg, F. (2014) · Cited by 2 · see citing works
Safety of Psychotropic Drugs in Children and Adolescents
Kaguelidou, F., & Acquaviva, É. (2015) · Springer eBooks · doi:10.1007/978-3-319-24741-0_13 · Cited by 2 · see citing works
Pharmacological Treatment of ADHD
Yadav, P. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-5495-1.ch008 · Cited by 2 · see citing works
Panei, P., Knellwolf, A., Arcieri, R., & Vella, S. (2006) · PEDIATRICS · doi:10.1542/peds.2005-1895 · Cited by 2 · see citing works
Etxebarria, X. T., & Pérez, M. F. (2006) · Hispana · Cited by 1 · see citing works
- Authors
- Poulton, A.
- Affiliations
- The University of Sydney (AU)
- Corresponding author
- Poulton, A
- ORCID
- Poulton, A
- Venue
- Archives of Disease in Childhood
- Publisher
- BMJ
- Published
- 2005-08-01
- Volume
- 90
- Issue
- 8
- Pages
- 801-806
- ISSN
- 0003-9888 (ISSN-L)
- 1468-2044
- PMC
- PMC1720538
- OpenAlex
- W2154426538
- Cited by
- 129
- References
- 42
- Citations by year
- 2025: 5 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 4 · 2020: 5 · 2019: 4 · 2018: 2 · 2017: 3 · 2016: 4 · 2015: 11 · 2014: 9 · 2013: 6 · 2012: 10
- FWCI
- 4.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Archives of Disease in Childhood (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- attention deficit hyperactivity disorder, stimulant medication, height growth, gastrointestinal adverse effects, children, adolescents, adults, height velocity
- MeSH terms
- Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Body Height, Child, Child, Preschool, Cross-Sectional Studies, Depression, Chemical, Female, Growth Disorders, Humans, Infant, Longitudinal Studies, Male
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
